Frequency of Pseudomonas aeruginosa colonizations/infections in lung transplant recipients

S Zeglen1, J Wojarski, E Wozniak-Grygiel

  • 1Department and Clinic of Cardiac Surgery and Transplantology, Silesian Medical University, Zabrze, Poland. slawekzeglen@poczta.onet.pl

Abstract

Insights

Lung transplant recipients face a high risk of Pseudomonas aeruginosa infections. This study found nearly 40% of patients had P. aeruginosa, highlighting the need for vigilant post-transplant care.

Area of Science:

  • Medical Microbiology
  • Transplant Surgery
  • Infectious Diseases

Background:

  • Lower respiratory tract infections are a major cause of death post-solid organ transplant.
  • Lung transplant recipients are especially vulnerable to infections early after surgery due to immunosuppression and invasive procedures.
  • Airway colonization by Pseudomonas aeruginosa is frequent in lung transplant patients.

Purpose of the Study:

  • To determine the frequency of Pseudomonas aeruginosa infections in lung transplant recipients at our center.
  • To analyze the incidence of P. aeruginosa airway colonization and lower respiratory tract infections post-lung transplantation.

Main Methods:

  • Retrospective analysis of 33 lung transplant (LT) cases performed between January 2004 and December 2008.
  • Routine microbiological examination of respiratory samples.
  • Inclusion of single, double, and heart-lung transplantations.

Main Results:

  • Pseudomonas aeruginosa was isolated from 39.4% (13/33) of lung transplant recipients.
  • Airway colonization with P. aeruginosa and subsequent lower respiratory tract infection occurred in 30.3% (10/33) of patients.
  • The annual incidence of P. aeruginosa diagnosis ranged from 33.3% to 57.1% between 2005 and 2008.

Conclusions:

  • Lung transplant recipients at this center exhibit a high risk of P. aeruginosa airway colonization and infection.
  • Pseudomonas aeruginosa poses a significant threat to the post-transplant outcomes of lung transplant recipients.
  • Early detection and management of P. aeruginosa are crucial for improving patient follow-up.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: